Rising incidence, health resource utilization, and costs of polycystic ovary syndrome in the United Kingdom

Berni, Thomas R., Morgan, Christopher L. and Rees, D. Aled ORCID: https://orcid.org/0000-0002-1165-9092 2024. Rising incidence, health resource utilization, and costs of polycystic ovary syndrome in the United Kingdom. Journal of Clinical Endocrinology and Metabolism 10.1210/clinem/dgae518

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (786kB) | Preview

Abstract

Context: Trends in incidence of polycystic ovary syndrome (PCOS) and effects on health resource utilization are unclear. Objective: To describe trends in prevalence and incidence of PCOS in the United Kingdom. To establish healthcare resource use and associated costs. Methods: Data were extracted from the Clinical Practice Research Datalink Aurum and Hospital Episode Statistics databases. Point prevalence and incidence were calculated (2004-2020). Patients with PCOS were matched to controls (1:1) by age, body mass index, and primary care practice. Primary care contacts were assigned an average cost and prescription items assigned a net ingredient cost. Inpatient admissions and outpatient consultations were processed into healthcare resource groups and costed to the national tariff. Results: PCOS incidence increased from 1.22 per 1000 person years in 2004 to 1.77 (2012) and 2.20 (2019). Point prevalence increased from 1.02% (2004) to 2.2% (2012) and 3.5% (2020), and was highest in Asians. Mean contacts per person year (ppy) for patients with PCOS vs controls were 0.48 vs 0.29 for inpatients (P < .001), 3.81 vs 2.15 for outpatients (P < .001), and 6.43 vs 4.68 (P < .001) for primary care. Mean healthcare costs (ppy) were £837 vs £493 (P < .001) for inpatients, £444 vs £253 (P < .001) for outpatients, £157 vs £112 for primary care, and £109 vs £83 (P < .001) for primary care prescriptions. Total healthcare contacts ppy were 10.72 vs 7.11 (P < .001) and total associated costs £1546 vs £940 (P < .001). Conclusion: The incidence of PCOS has risen significantly. Health resource utilization and costs of PCOS are significantly greater than controls. Key Words: polycystic ovary syndrome, incidence, prevalence, costs and cost analysis, health resources, ethnicity

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Oxford University Press
ISSN:	0021-972X
Date of First Compliant Deposit:	13 August 2024
Date of Acceptance:	23 July 2024
Last Modified:	15 Aug 2024 13:56
URI:	https://orca.cardiff.ac.uk/id/eprint/171361

Actions (repository staff only)

Edit Item